DUBLIN, July 1, 2013 /PRNewswire/ -- PR Newswire (press release) The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constituting four of the global top 20 best-selling drugs. The unique density of monoclonal antibodies that are ... |